Researcher
Bert Bammens
- Disciplines:Urology and nephrology
Affiliations
- Nephrology and Renal Transplantation Research Group (Division)
Member
From1 Oct 2001 → Today
Projects
1 - 6 of 6
- Cytopenia and autosomal dominant polycystic kidney disease.From1 Jan 2021 → 31 Dec 2021Funding: Private funding of national origin - undefined
- Automated slide scanner for digitalizing histopathologyFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Cytopenia and Autosomal Dominant Polycystic Kidney Disease (ADPKD)From1 Nov 2020 → TodayFunding: FWO fellowships
- Clinical and fundamental aspects of autosomal polycystic kidney diseaseFrom23 Nov 2016 → 4 Dec 2020Funding: FWO fellowships
- Live fluorescence imaging system in environmental controlled stable conditionsFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Heme oxygenase-1 and chronic kidney disease: A translational study of oxidative stress and atherogenesisFrom1 Oct 2010 → 1 Dec 2016Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 147
- HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial(2024)
Authors: Bert Bammens
- Standardized 4-point scoring scale of [18F]-FDG PET/CT imaging helps in the diagnosis of renal and hepatic cyst infections in patients with autosomal dominant polycystic kidney disease: a validation cohort.(2023)
Authors: Djalila Mekahli, Bert Bammens, Karolien Goffin
Pages: 2542 - 2548 - Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up(2023)
Authors: Elisabet Van Loon, Maarten Coemans, Isabelle Meyts, Rudi Vennekens, Dirk Kuypers, Djalila Mekahli, Bert Bammens
Pages: 2578 - 2586 - Low agreement between various eGFR formulae in pediatric and young adult ADPKD patients(2023)
Authors: Karel Allegaert, Bert Bammens, Rudi Vennekens, Pieter Vermeersch, Hans Pottel, Djalila Mekahli
Pages: 3043 - 3053 - Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function(2023)
Authors: Jean-Paul Decuypere, Rudi Vennekens, Bert Bammens, Djalila Mekahli
Pages: 1907 - 1911 - RAPIDLY PROGRESSIVE AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE : RISK FACTORS FOR DISEASE SEVERITY DURING CHILDHOOD AND EARLY ADULTHOOD(2023)
Authors: Bert Bammens, Djalila Mekahli
Pages: I9 - I9 - Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry(2023)
Authors: Frederik De Keyzer, Rudi Vennekens, Bert Bammens, Chantal Van Ongeval, Djalila Mekahli
Pages: 581 - 591 - Safety, Efficacy, and Predictors for Late Reintervention After Embolization of Renal Angiomyolipomas - Embolization renal angiomyolipoma(2023)
Authors: Annouschka Laenen, Bert Bammens, Maarten Albersen, Geert Maleux
Pages: 319 - 325 - The emerging role of the apelinergic system in kidney physiology and disease(2022)
Authors: Jean-Paul Decuypere, Bert Bammens, Rudi Vennekens, Djalila Mekahli
Pages: 2314 - 2326 - On Methods for the Measurement of the Apelin Receptor Ligand Apelin(2022)
Authors: Jean-Paul Decuypere, Rudi Vennekens, Djalila Mekahli, Bert Bammens